We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Michael Kinch, PhD

Michael Kinch, PhD profile page


Michael S. Kinch is Dean of Science, Vice President for Innovation and director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Long Island University. He is the author of Between Hope and Fear: A History of Vaccines and Human Immunity, The End of the Beginning: Cancer, Immunity and the Future of a Cure and A Prescription for Change: The Looming Crisis in Drug Development.


Got a Question for Michael Kinch, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 11
A woman sits at a desk working on a laptop in front of a large window.
Article

Pharma's Push To Resume In-Person Work Carries Consequences

This article explores the potential implications of big pharma companies urging their employees to return to in-person work and how this could impact the pharmaceutical sector.
A sign listed on a window that reads "proof of vaccination required".
Article

Is It Finally Time To Discuss Vaccine Mandates?

In this op-ed, Professor Michael S. Kinch argues that the only way we can the COVID-19 pandemic is "to mandate that all individuals are not merely vaccinated but remain up to date with boosters."
An image depicting artificial intelligence.
Article

ChatGPT: It’s Not the End of the World as We Know It

In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.
Egg on Our Face: Another Asilomar Moment? content piece image
Article

Egg on Our Face: Another Asilomar Moment?

Michael Kinch confronts a recent controversy in the field of immunology, where researchers failed to seek permission or guidance from the NIAID before engineering mutant forms of SARS-CoV-2.
A Degeneration of Trust content piece image
Article

A Degeneration of Trust

Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.
The Vaccination Divide: Where Pathogens Meet Politics content piece image
Article

The Vaccination Divide: Where Pathogens Meet Politics

In this opinion article, Michael S Kinch considers the links between vaccination skepticism and politics, sentiments that were deeply entrenched in society before the first vaccine was discovered in the eighteenth century.
Why Ever More Boosters Could Hurt More Than Help content piece image
Article

Why Ever More Boosters Could Hurt More Than Help

In this opinion article, Michael S Kinch explains why the calls for additional booster shots to combat the COVID-19 pandemic is, from his perspective, increasingly troubling.
A Note to the Vaccinated: Thank You and Be Reassured content piece image
Article

A Note to the Vaccinated: Thank You and Be Reassured

Recent headlines sparked fear after discussing waning immunity to SARS-CoV-2 after vaccination. In this op-ed, immunologist Michael Kinch addresses the subject of the articles and explains why it is normal for antibody levels in the blood to wane over time.
The Alpha and Omega of COVID-19: Yes, the Pandemic Will End (but Not Soon) content piece image
Article

The Alpha and Omega of COVID-19: Yes, the Pandemic Will End (but Not Soon)

The omega of the pandemic is in sight. To achieve this, we must all work together not merely to develop these new technologies, but to ensure that they are widely and appropriately accepted by the public.
Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents content piece image
Article

Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents

In this op-ed piece, Michael S. Kinch, director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis, explores the issue of eliminating patent protection for COVID-19 vaccines.
Advertisement